​

Humana (HUM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HUM Stock Forecast

Humana (HUM) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $314.33, with a high of $348.00 and a low of $280.00. This represents a 14.90% increase from the last price of $273.58.

$250 $300 $350 $400 $450 $500 High: $348 Avg: $314.33 Low: $280 Last Closed Price: $273.58

HUM Stock Rating

Humana stock's rating consensus is Hold, based on 42 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (33.33%), 28 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 42 28 14 0 Strong Sell Sell Hold Buy Strong Buy

HUM Price Target Upside V Benchmarks

TypeNameUpside
StockHumana14.90%
SectorHealthcare Stocks 13.55%
IndustryHealthcare Plans Stocks25.41%

Price Target Trends

1M3M12M
# Anlaysts2614
Avg Price Target$320.00$301.83$286.93
Last Closing Price$273.58$273.58$273.58
Upside/Downside16.97%10.33%4.88%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 252617--25
Aug, 252616--24
Jul, 253617--26
Jun, 253617--26
May, 253618--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 04, 2025Andrew MokBarclays$315.00$312.000.96%15.14%
Sep 04, 2025Andrew MokBarclays$325.00$311.984.17%18.80%
Jul 31, 2025Andrew MokBarclays$275.00$261.475.17%0.52%
Jul 18, 2025Stephen BaxterWells Fargo$348.00$217.1460.27%27.20%
Jun 17, 2025David MacDonaldTruist Financial$280.00$241.4515.97%2.35%
Jun 12, 2025Andrew MokBarclays$268.00$234.9614.06%-2.04%
Dec 04, 2024George HillDeutsche Bank$248.00$287.65-13.78%-9.35%
Oct 22, 2024George HillDeutsche Bank$250.00$260.57-4.06%-8.62%
Oct 10, 2024Andrew MokBarclays$250.00$245.451.85%-8.62%
Oct 08, 2024Ben HendrixRBC Capital$265.00$236.2912.15%-3.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 04, 2024Deutsche BankHoldHoldhold
Nov 06, 2024Bank of America SecuritiesNeutralNeutralupgrade
Oct 22, 2024Deutsche BankHoldHoldhold
Oct 11, 2024OppenheimerOutperformOutperformhold
Oct 10, 2024KeyBancSector Weightinitialise
Oct 10, 2024BarclaysEqual-WeightEqual-Weighthold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Oct 08, 2024BernsteinMarket PerformOutperformupgrade
Oct 07, 2024Zacks Investment ResearchNegativedowngrade
Oct 07, 2024Cowen & Co.BuyHolddowngrade

Financial Forecast

EPS Forecast

$10 $17 $24 $31 $38 $45 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$25.47$22.79$22.20$20.09$10.02----
Avg Forecast$18.66$20.54$25.06$27.17$16.15$16.73$14.11$23.92$38.29
High Forecast$19.53$21.49$26.44$27.47$16.29$17.53$16.80$30.54$41.24
Low Forecast$18.22$20.04$24.16$25.31$15.89$16.19$11.18$18.59$36.48
Surprise %36.50%10.95%-11.41%-26.06%-37.96%----

Revenue Forecast

$70B $85B $100B $115B $130B $145B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$77.16B$83.06B$92.87B$106.37B$117.76B----
Avg Forecast$76.06B$83.07B$92.96B$104.82B$117.02B$119.65B$120.24B$127.73B$134.70B
High Forecast$78.78B$86.04B$96.92B$105.19B$117.38B$125.04B$120.47B$128.10B$142.69B
Low Forecast$74.65B$81.54B$90.40B$104.65B$116.54B$116.84B$120.01B$127.35B$129.81B
Surprise %1.44%-0.01%-0.09%1.49%0.63%----

Net Income Forecast

$1B $2B $3B $4B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.37B$2.93B$2.81B$2.49B$1.21B----
Avg Forecast$2.75B$2.79B$2.95B$2.49B$2.00B$2.10B$1.59B$2.40B$4.76B
High Forecast$3.41B$3.35B$3.55B$2.99B$2.03B$2.18B$2.09B$3.80B$5.13B
Low Forecast$2.09B$2.22B$2.36B$1.99B$1.98B$2.01B$1.39B$2.31B$4.54B
Surprise %22.45%5.24%-4.94%--39.70%----

HUM Forecast FAQ

Is Humana stock a buy?

Humana stock has a consensus rating of Hold, based on 42 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 28 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Humana is a neutral investment for most analysts.

What is Humana's price target?

Humana's price target, set by 42 Wall Street analysts, averages $314.33 over the next 12 months. The price target range spans from $280 at the low end to $348 at the high end, suggesting a potential 14.90% change from the previous closing price of $273.58.

How does Humana stock forecast compare to its benchmarks?

Humana's stock forecast shows a 14.90% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the healthcare plans stocks industry (25.41%).

What is the breakdown of analyst ratings for Humana over the past three months?

  • September 2025: 8.00% Strong Buy, 24.00% Buy, 68.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 8.33% Strong Buy, 25.00% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 11.54% Strong Buy, 23.08% Buy, 65.38% Hold, 0% Sell, 0% Strong Sell.

What is Humana’s EPS forecast?

Humana's average annual EPS forecast for its fiscal year ending in December 2025 is $16.73, marking a 66.97% increase from the reported $10.02 in 2024. Estimates for the following years are $14.11 in 2026, $23.92 in 2027, and $38.29 in 2028.

What is Humana’s revenue forecast?

Humana's average annual revenue forecast for its fiscal year ending in December 2025 is $119.65B, reflecting a 1.60% increase from the reported $117.76B in 2024. The forecast for 2026 is $120.24B, followed by $127.73B for 2027, and $134.7B for 2028.

What is Humana’s net income forecast?

Humana's net income forecast for the fiscal year ending in December 2025 stands at $2.1B, representing an 73.85% increase from the reported $1.21B in 2024. Projections indicate $1.59B in 2026, $2.4B in 2027, and $4.76B in 2028.